In hepatoma cells, silencing KIF18A reduced the expression of cyclin B1, MMP-9, MMP-7, and Akt-related proteins and inhibited hepatoma cell growth, invasion, and metastasis (20). The gene discussed is AKT1; the disease is hepatocellular carcinoma.